Efficacy and Safety of Darunavir/Ritonavir at 48 Weeks in Treatment-naïve, HIV-1–infected Adolescents
Patricia M. Flynn(St. Jude Children's Research Hospital), Magda Opsomer(Janssen (Belgium)), Carlo Giaquinto(University of Padua), Svitlana Komar(Janssen (Belgium)), Steven Welch(University Hospitals Birmingham NHS Foundation Trust), Tom Van de Casteele(St. Jude Children's Research Hospital), Antoni Noguera‐Julián(Hospital Sant Joan de Déu Barcelona), Erkki Lathouwers(Janssen (Belgium)), Thomas N. Kakuda(Johnson & Johnson (United States)), Stéphane Blanche(Délégation Paris 5)
Cited by 28
Related Papers
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k
Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy
|Science|2009|1.5k
Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection
|New England Journal of Medicine|1996|878